Storyline
After a tumultuous tenure marked by recent clashes with the biopharma industry, Vinay Prasad, M.D., will be departing his post as the FDA’s top regulator of ...
CBER chief Vinay Prasad to leave FDA once again Phil.Taylor Sun, 08/03/2026 - 19:20.
Evidence locked
Today's free sample is only available for the edition's flagship storyline.
Evidence preview
- After a tumultuous tenure marked by recent clashes with the biopharma industry, Vinay Prasad, M.D., will be departing...Fierce Pharma (All)
- CBER chief Vinay Prasad to leave FDA once againpharmaphorum